New triple pill combo aims to tame type 2 diabetes
NCT ID NCT07026968
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 32 times
Summary
This study tests whether adding two new drugs (prusogliptin and dapagliflozin) to standard metformin can improve blood sugar control in adults with type 2 diabetes. About 815 participants who are not well-controlled on metformin alone will receive either the triple combination or a placebo. The main goal is to see if the triple therapy lowers HbA1c (a key blood sugar measure) more effectively over 24 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
No. 896, Zhongshan East Road, High-tech Industrial Development Zone
Shijiazhuang, Hebei, 050035, China
Conditions
Explore the condition pages connected to this study.